Previous Post
Next Post

The Biggest Joke On Wall Street: Genova Biotherapeutics Inc. (GVBP) Ends “Relationship” With Bridge BioResearch After 4 Days (LOL)

Posted by Timothy Sykes on Sat 19th of Sep, 2009 12:45:40 PM
  Tags:

UPDATE: You gotta see the latest breaking research on GVBP using recycled press releases, too funny/disgusting!

GVBP just ended their “relationship” with Bridge Bio after an amazingly long 4-day stretch…LOL…they released THIS PR late Friday night hoping people wouldn’t notice…you can see the beginning of this fruitful “relationship in this September 14th PR…whoops, little Timmy noticed and he’s gonna make sure everyone else notices too…WHAT A TOTAL SHAM THIS IS, BRIDGE BIO PROBLY FIGURED THAT OUT AND WANTS NOTHING TO DO WITH IT!

Check out the 2 PRs copied below and realize that this pump & dump is looking like it could unravel fast, especially considering there’s a guy out there with 100 million shares to sell (he’s already sold just under 3 million shares, I wonder what he thinks of this partnership?!?!?!?!)

September 18th 8:25PM EST PR “GENova Bio ends relationship with Bridge BioResearch”

NEW YORK, NY, Sept. 18 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB - News) - GENova Biotherapeutics Inc. (”GENova”) today announced that it has ceased the relationship with Bridge BioResearch PLC and unconditionally retract the announcement made earlier this month and GENova further announced that Mr. Anders Bogh Jensen, Chief Science Officer of Bridge BioResearch PLC, will not be serving on the GENova’s Scientific Advisory Board.

September 14th 4:30PM EST PR “GENova Biotherapeutics signs collaboration agreement with Bridge Bioresearch”

NEW YORK, NY, Sept. 14 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB - News) - GENova Biotherapeutics Inc. (”GENova”) today announced it has signed a collaboration agreement with Bridge Bioresearch Plc. (”Bridge Bioresearch”), an international drug development and discovery company that focuses on metabolic disorders.

The two biotechnology drug acquisition companies plan to leverage each others’ scientific findings and industry contacts for mutual gain.

GENova’s business solely focuses on cancer cures, while Bridge BioResearch is geared at acquiring drug targets for Obesity and Type 2 Diabetes. Through the collaboration agreement, the two companies will partner to share research results and their global contacts with research organizations and pharmaceutical companies. They will also examine their findings to gain insight into the links between their respective fields of oncology and obesity, as cancer and obesity are both maladies that can be blamed on lifestyle choices.

“By collaborating with Bridge BioResearch, we will gain access to their excellent network of high quality research labs and universities around the world, as well as their well-established distribution channels,” says Aaron Whiteman, CEO for GENova. “We are confident that through this collaboration, we will gain access to the latest and greatest in developmental cancer drugs to perpetuate our acquisition pipeline, as well as secure reliable distribution channels for our out-licensing objectives.”

“Furthermore, through this collaboration, we will exchange our scientific findings to gain insight into the links between obesity and cancer, as many findings suggest that one of the main factors in cancer development is lifestyle choices, including unhealthy diet,” says Whiteman.

I WONDER WHAT THE NEXT SHOE TO DROP WILL BE, SEC HALT? A RETRACTION OF ANOTHER PARTNERSHIP?

I’m pumped (hahaha get it) to be short 30,000 shares of this stock, which I consider to be worthless…absolutely worthless…yup worthless…in 10 years, I’ve never seen such a BLATANT PUMP & DUMP, LEARN PEOPLE!

Spread This Post:
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • MySpace
  • StumbleUpon
  • Technorati
  • TwitThis
  • Yahoo! Buzz

TIMstore Monthly DVD Specials:

See all TIM DVD specials HERE

Related Reading

Previous Post
Next Post
  • 9551Scott
    GEEEEzzzzzzzzz, just got though watchin' the guy on the chart (previous blog)and he almost put me to sleep. Your're right Tim, either a Gump or paid pump. Or maybe he just eats walnuts for breakfast. Some chart guys have blinders glued on to their noggin's and haven't a clue about proper DD. Anyway, CVBP will go south to 7-8 centavos, Mr. Whiteman will be bannished to shinnin' shoes in New Delhi, and we'll all get our teeth fixed.
  • 9551Scott
    OH....another thing.. You ought to put out another 15k on this super loser if you can find the shares. Yep, a deal like this only comes around once in a blue moon. Uh oh ...just slobbered on myself.
  • kris
    what brokers out there let you short pennies? i want to short this pump and dump into the ground. Once the paid prs are done and the shares are dumped this will go into .0001 land.
  • 9551Scott
    Your best shots are THINK AND SWIM & INTERACTICE BROKERS. IR ain't as good but usually have more shares to go south with.
  • 9551Scott
    Check that.........ThinkORSwim........
  • msklar
    I called tos to try shorting this at around a dollar as i saw it dropping fast and they told me I cant short under $3 stocks...I told them im a member of tim sykes an affiliate of theres and he does it all the time.. they where like so? you cant short under $3.....that was the only reason i switched from scottrade..wtf?
  • Timmy,

    IT GETS BETTER. From My research on this P & D, I have discovered CLEAR SEC violations. The "Bark" Group is the HEAD Pump, that was hired by Bark Copenhagens Plc. The Bark Group in the US is paying Henrik Rouf owner of PAcific Impact Funding a 10% royalty for winkwink "advertising", Henrik rouf is a Principal of the Clear Vision. The WinkWink Director of Asian Business Development works for http://www.clearvisionadvisors.com/main.html AS WELL!!!!BAAAAAAAAAAAAAAHAAAAAAAAAAAAAAAAAAAAA. Anyway, I am going to get 10,000 SS's myself on Monday, would have done it Friday but could not get to it in time, far to much DD. But Mark My Words, this POS will be SUBPeNNY before the end of the year,. if or until the SEC shuts it down!! I email hrouf@yahoo.com and told he was a POS. Also called the I/R guy that got in Vegas!!LMAO, bro, I swear the guy was doing Lines as i was tlaking to him, an out of work Mortgage Broker manning the phones for this pump!!!LMAO>>>.
  • 9551Scott
    Nice job Doc...

    Here's another joke....read SEC filings on RPRX if haven't already.
blog comments powered by Disqus




Start Here

Who Is Timothy Sykes And Why Should I Care?

See Tim's full bio HERE. Tim turned a few thousand dollars into a few million by taking small gains time after time on hundreds of volatile penny stocks, discovering that his trading strategy, while consistently successful, works best for those with smaller accounts.

Determined to teach others this PennyStocking trading strategy (learn more HERE), he went back to his original $12,415 roots (already $58,000+ even though the stock market has crashed) to show everyone how to turn thousands into millions, even while having a life (somewhat) and making plenty of mistakes. Currently he is the #1 ranked trader out of 25,000+ on Covestor)

How Can I Consistently Make Money In The Stock Market?

Hard work, Determination and Know How.

Hard work to learn how the greatly misunderstood niche of penny stocks provides opportunities every now and then on which you should pounce.

Determination to seek those probable profits out and know how in order to actually profit from them.

Long story short, wait for stocks that are extremely volatile - for whatever reason - and then aim to take small profits (between 10 and 50% within a few hours, days or weeks) here and there, either from betting on higher or lower prices (yes, you can make $ betting on lower prices, it's called Shortstocking (learn more HERE).

Why Penny Stocks?

As Tim explains in several ALL-NEW instructional DVDs (see them HERE) and in over 2000+ blog posts, penny stocks are the most hyped and corrupt niche in the entire investment world. These two qualities make them the easiest to profit from (legally) because the vast majority of people who play penny stocks are suckers and all-around ignorant people. If you have any intelligence whatsoever, you have a clear advantage and it's like playing basketball against mental midgets.

Where Do You Find Stocks To Trade?

This is the #1 FAQ (see more HERE) and it is answered in THIS instructional DVD.

Of course, that's just a brief introduction - to receive a full education, there is Tim's book An American Hedge Fund which is the story of his remarkable rise and lessons learned.

To truly increase your odds at profit, Tim has designed an entire set of detailed instructional DVDs, covering all the variables that amount to over 24 hours of instruction (see them all HERE)!

TIM Trades

View All
Date Stock Buy Sell Net
Nov 19 AENY $2.80 $3.02 $1148
Nov 18 NLST $4.16 $4.40 $947
Nov 18 IMGG $1.42 $1.64 $2094
Nov 17 NLST $5.04 $5.59 $2195
Nov 13 VRMLQ $21.50 $22.97 $2901
Nov 11 EONC $2.61 $2.80 $687
Nov 10 EONC $2.74 $3.36 $9784
Nov 6 QXM $4.31 $4.80 $1936
Nov 4 COT $8.66 $8.88 $642
Nov 4 QXM $4.61 $4.89 $822
Oct 30 DDRX $25.70 $26.53 $812
Oct 29 CTDC $4.00 $4.42 $781
Oct 26 AWSL $3.24 $4.10 $2516
Oct 23 RODM $5.27 $5.23 $301
Oct 22 AMLM $2.69 $2.97 $820
Oct 22 USEG $6.12 $6.09 $85
Oct 20 CBOU $8.93 $9.06 $243
Oct 16 VRMLQ $16.79 $18.65 $2773
Oct 13 YONG $11.05 $11.66 $1202
Oct 13 NPHC $0.59 $0.71 $583
Oct 12 IMGG $0.60 $0.70 $682
Oct 9 ZAGG $5.50 $6.10 $2380
Oct 7 GVBP $0.03 $0.27 $702
Oct 1 NPHC $0.70 $0.85 $1482

Total: $98,094 (681%)